← Back to Clinical Trials
Recruiting NCT06602141

NCT06602141 Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06602141
Status Recruiting
Phase
Sponsor AdventHealth Translational Research Institute
Condition Obesity
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2024-09-11
Primary Completion 2029-04

Trial Parameters

Condition Obesity
Sponsor AdventHealth Translational Research Institute
Study Type INTERVENTIONAL
Phase N/A
Enrollment 70
Sex ALL
Min Age 18 Years
Max Age 45 Years
Start Date 2024-09-11
Completion 2029-04
Interventions
Muscle BiopsyAdipose BiopsyGlucose Clamp

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this research study is to study the effects of endurance exercise training on adipose (fat) tissue quality and insulin sensitivity in men and women.

Eligibility Criteria

Inclusion Criteria: 1. Men and pre-menopausal women; 2. 18-45 years of age; 3. BMI 30.0-40.0 kg/m2; 4. For women, if not using pharmaceutical (hormonal) contraception (i.e. birth control pills, vaginal ring, injections, or implant), must agree to use either a double barrier method as a form of birth control to prevent pregnancy (i.e. male condom with spermicide, with or without cervical cap or diaphragm); use implants or intrauterine contraceptive devices; have a tubal ligation (surgically sterile); practice abstinence; or be in an established relationship with a vasectomized or same sex partner during the entire duration of the study; 5. Able to speak and understand written and spoken English; 6. Sedentary defined as self-reporting no more than 1 day per week, lasting no more than 60 minutes, of regular (structured) endurance or resistance exercise in the past year. 7. Must be willing to be randomized to either study group; 8. Must be willing to adhere to all study procedures. 9. Part

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology